23046 Avenida de la Carlota, Suite 360 | Laguna Hills, CA 92653 | 949.951.1348

About Us


Our Vision

To become the premier developer of unique, proprietary prescription pharmaceutical products that address unmet needs in ophthalmology.

Mission Statement

We strive to leverage our knowledge and expertise in the areas of dry eye disease, glaucoma and retinal disease to bring exciting new therapeutic modalities to these rapidly growing market segments.

Business Development

We are actively seeking to expand our pipeline through strategic in-licenses, acquisitions and commercialization alliances. Inquiries can be emailed to Martyn Gunning at mgunning@alacritybio.com.

Our Vision
Management Team
David F. Power — President and CEO
Karin Ludwig, M.D. — Chief Medical Officer
Martyn I. Gunning — VP, Business Development
Scientific Advisory Board
Stephen C. Pflugfelder, M.D.
Marguerite B. McDonald, M.D.
Ronald L. Gross, M.D.
Jeffrey S. Heier, M.D.
Board of Directors
Neil Herskowitz
Michael Weiser, M.D., Ph.D.
John Graham
David F. Power
J. William Doyle, M.D.
Timothy M. Hofer
Read more about our leading pharmaceutical development project: ALTY-0501.
Copyright© 2007 Alacrity Biosciences